Terms: = Kidney tumors AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
22 results:
1. Nanobody-loaded nanobubbles targeting the G250 antigen with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities for specifically enhanced imaging of RCC.
Chen J; Li J; Zhong C; Ling Y; Liu D; Li X; Xu J; Liu Q; Guo Y; Wang L
Nanoscale; 2023 Dec; 16(1):343-359. PubMed ID: 38062769
[TBL] [Abstract] [Full Text] [Related]
2. Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma.
Zhong C; Chen J; Ling Y; Liu D; Xu J; Wang L; Ge C; Jiang Q
Int J Nanomedicine; 2023; 18():2757-2776. PubMed ID: 37250472
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Wang L; Wang H; Wang T; Liu J; Chen W; Wang Y; Chen C; Zhu H; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1101-1112. PubMed ID: 30942098
[TBL] [Abstract] [Full Text] [Related]
5. Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Koster BD; Santegoets SJAM; Harting J; Baars A; van Ham SM; Scheper RJ; Hooijberg E; de Gruijl TD; van den Eertwegh AJM
Cancer Immunol Immunother; 2019 Jun; 68(6):1025-1035. PubMed ID: 30852622
[TBL] [Abstract] [Full Text] [Related]
6. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of an Anti-HER2 Nanobody Labeled with
Pruszynski M; D'Huyvetter M; Bruchertseifer F; Morgenstern A; Lahoutte T
Mol Pharm; 2018 Apr; 15(4):1457-1466. PubMed ID: 29502411
[TBL] [Abstract] [Full Text] [Related]
8. Diffusion-weighted MRI for differentiating Wilms tumor from neuroblastoma.
Aslan M; Aslan A; Arıöz Habibi H; Kalyoncu Uçar A; Özmen E; Bakan S; Kuruğoğlu S; Adaletli İ
Diagn Interv Radiol; 2017; 23(5):403-406. PubMed ID: 28830846
[TBL] [Abstract] [Full Text] [Related]
9. DNA repair system and renal cell carcinoma prognosis: under the influence of nbs1.
Rosinha A; Assis J; Dias F; Nogueira A; Pereira D; Maurício J; Teixeira AL; Medeiros R
Med Oncol; 2015 Nov; 32(11):255. PubMed ID: 26493193
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative surgical simulation of laparoscopic adrenalectomy for neuroblastoma using a three-dimensional printed model based on preoperative CT images.
Souzaki R; Kinoshita Y; Ieiri S; Kawakubo N; Obata S; Jimbo T; Koga Y; Hashizume M; Taguchi T
J Pediatr Surg; 2015 Dec; 50(12):2112-5. PubMed ID: 26440294
[TBL] [Abstract] [Full Text] [Related]
11. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
Zhong X; Yang H; Zhao S; Shyr Y; Li B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
[TBL] [Abstract] [Full Text] [Related]
12. Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.
Poté N; Vieillefond A; Couturier J; Arrufat S; Metzger I; Delongchamps NB; Camparo P; Mège-Lechevallier F; Molinié V; Sibony M
Virchows Arch; 2013 Jun; 462(6):633-8. PubMed ID: 23708994
[TBL] [Abstract] [Full Text] [Related]
13. Is the nbn gene mutation I171V a potential risk factor for malignant solid tumors in children?
Nowak J; Mosor M; Nowicka K; Rembowska J; Januszkiewicz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
[TBL] [Abstract] [Full Text] [Related]
14. The role of WT1 gene in neuroblastoma.
Wang J; Oue T; Uehara S; Yamanaka H; Oji Y; Fukuzawa M
J Pediatr Surg; 2011 Feb; 46(2):326-31. PubMed ID: 21292082
[TBL] [Abstract] [Full Text] [Related]
15. A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Jeong SH; Lee JS; Jeong NY; Kim TH; Yoo KS; Song S; Suh H; Kwon TK; Park BS; Yoo YH
Int J Oncol; 2009 Dec; 35(6):1353-60. PubMed ID: 19885558
[TBL] [Abstract] [Full Text] [Related]
16. N terminus of CtIP is critical for homologous recombination-mediated double-strand break repair.
Yuan J; Chen J
J Biol Chem; 2009 Nov; 284(46):31746-52. PubMed ID: 19759395
[TBL] [Abstract] [Full Text] [Related]
17. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.
Margulis V; Lin J; Yang H; Wang W; Wood CG; Wu X
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2366-73. PubMed ID: 18768505
[TBL] [Abstract] [Full Text] [Related]
18. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.
Okamura N; Masuda T; Gotoh A; Shirakawa T; Terao S; Kaneko N; Suganuma K; Watanabe M; Matsubara T; Seto R; Matsumoto J; Kawakami M; Yamamori M; Nakamura T; Yagami T; Sakaeda T; Fujisawa M; Nishimura O; Okumura K
Proteomics; 2008 Aug; 8(15):3194-203. PubMed ID: 18615424
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical and genealogical characteristics in families with Nijmegen breakage syndrome].
Kitsera NI; Polishchuk RS; Akopian HR; Markevych NV; Kostiuchenko LV; Troianovs'ka OO; Skoropad LL
Tsitol Genet; 2005; 39(2):72-8. PubMed ID: 16161417
[TBL] [Abstract] [Full Text] [Related]
20. SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma.
Astuti D; Da Silva NF; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher ER
Br J Cancer; 2004 Jan; 90(2):515-21. PubMed ID: 14735202
[TBL] [Abstract] [Full Text] [Related]
[Next]
